Is Sale of Specialty Pharmacy Accelerator Shields in Walgreens’ Best Interests?
Less than two years after Walgreens Boots Alliance Inc.’s purchase of Shields Health Solutions, the pharmacy giant is rumored to be seeking a sale of the health system-owned specialty pharmacy integrator, per a Jan. 23 Bloomberg article, which valued the company at around $4 billion. While returns from a sale could help the company shore up certain units, divesting itself of Shields at a time when specialty pharmacy continues to be a hot commodity may be a questionable approach, say industry experts.
A Walgreens spokesperson told AIS Health, a division of MMIT, that the company has no comment.
© 2024 MMIT